ActiveNANCT05877729

iVY: Comprehensive, Tailored, Technology-based Intervention to Improve Virologic Suppression Among Youth and Young Adults Living With HIV

Sponsor: University of California, San Francisco

Trial Details

ConditionHIV/AIDS, Young Adult, Mobile Health, Mental Health Issue, Substance Use
InterventionStandard of Care; Video-counseling+app
PhaseNA
StatusActive
Participants200
Est. Completion24 Apr 2026
Last Updated12 May 2026

Primary Outcome

HIV Viral Load Suppression Comparison Evaluated Using Home-collected Hemaspot Device

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: 1. 18-29 years of age 2. HIV seropositive 3. Live and receive HIV care in California or Florida 4. Diagnosed with HIV more than 3 months ago 5. HIV VL test result of ≥20 copies at some point in the last 12 months (excluding tests within 3 mo of diagnosis) 6. Able to speak English 7. Have access to smartphone Exclusion Criteria: 1. Unable or unwilling to provide consent. 2. Evidence of severe cognitive impairment, active psychosis, or substance use that may impede ability to provide informed consent during the consent process. 3. Those with a history of hemophilia or unable to conduct finger prick at home for the HIV viral load testing.

Trial Sites

Countries

United States
View Registry Entry

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service